Vall d'Hebron Hospital General

What Vall d'Hebron Hospital General does

Vall d'Hebron Barcelona Hospital Campus is a public university hospital and integrated health campus in Barcelona, Spain, founded in 1955 and operated as a non-profit foundation (Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, NIF G-60.594.009) within the Catalan Institute of Health (Institut Català de la Salut). It serves the general patient population of Catalonia and Spain across all medical and surgical specialties, including high-complexity care in transplant medicine (kidney, liver, lung, hematopoietic stem cell), CAR-T cell therapy, robotic surgery via two Da Vinci systems (the only dual-site deployment in Spain), oncology (through VHIO), multiple sclerosis (Cemcat), pediatric and maternal care, and rare diseases (50+ CSUR-accredited programs). The campus is also a major clinical research site, recording 1,580 active clinical trials in 2021 and sustaining high activity through 2025-2026, supported by the VHIR research institute, the VHIO oncology institute, and the UAB teaching unit.

The campus combines clinical care, biomedical research, teaching, and innovation across five co-located institutions. Core technological capabilities include the dual Da Vinci robotic theatres, an adult ECMO program with 700+ procedures, the IMMUNOMICS-VHIO ultrasensitive liquid biopsy platform, a 3D Technologies Unit authorized to manufacture custom-made medical devices, an Advanced Clinical Simulation Centre, and the Data Space (Espai de Dades) integrating clinical and research data. Digital patient-facing assets include the El Meu Vall d'Hebron private portal and Smart Campus mobile initiatives. Research is consolidated under VHIO's renewed Severo Ochoa Centre of Excellence accreditation and the pediatric transplant program's JACIE reaccreditation.

The business model is primarily public reimbursement through the Catalan Health Service (Servei Català de la Salut) and the Spanish National Health System under government-set fee schedules, supplemented by competitive research grants (PERIS, EU framework programs, pharmaceutical-sponsored clinical trials managed via the IQVIA Prime Site agreement), philanthropy (notably Fundació Cellex since 1999, Fundació La Caixa), and European Reference Network (ERN) cross-border rare-disease activity. Distribution occurs through public referrals, emergency access, interhospital transfers for CSUR-designated conditions, and teaching/research channels including 149 medical residency positions across 46 specialties. The customer base is broadly distributed across the general population, with strategic concentration in the Catalan public payer and a small number of major philanthropic and pharmaceutical partners.

Name

Vall d'Hebron Hospital General

Legal name

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca

Website

https://vallhebron.com

Company type

Private

Founded year

1955

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Vall d'Hebron Barcelona Hospital Campus is a public university hospital and integrated health campus in Barcelona, Spain, combining clinical care, biomedical research (VHIR, VHIO), teaching, and innovation across five institutions. It serves the general population plus complex cases in transplants, oncology, robotics, CAR-T, and 50+ rare-disease reference programs.

Ownership category

akta.pro rank

Product category

Public Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Transplant Specialty Hospitals (HLAFAHAE)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Trauma Centers & Level I–IV Trauma Hospitals (HLAFAAAK), Children’s Hospitals (Acute Care) (HLAFAAAI)

Keywords

• Public hospital services
• Biomedical research
• Medical education training
• Transplant programs
• Oncology treatment

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Public Healthcare Service Delivery: As a public university hospital within the Catalan Health Service (Servei Català de la Salut), Vall d'Hebron operates under the Spanish public healthcare framework, providing medical services funded through public health system reimbursement and government allocations.
2. Research Grants and Funding: Competitive public and European research grants, including PERIS grants, EU framework programs, pharmaceutical-sponsored clinical trials, and institutional research funding through VHIR and VHIO.
3. Philanthropy and Donations: Donations from individuals, foundations, and corporate partners for hospital and research purposes. Includes legacies, solidarity initiatives, and charitable donations directed at patient experience or specific research projects.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

Vall d'Hebron Barcelona Hospital Campus is a public university hospital campus providing comprehensive healthcare services across all medical and surgical specialties, integrated with biomedical research, medical teaching, and innovation. The campus combines a general hospital, children's and women's hospital, two research institutes (VHIR and VHIO), a multiple sclerosis center (Cemcat), and a university teaching unit. It delivers high-complexity care including transplant programs, CAR-T therapy, robotic surgery, and oncology, supported by 1,580+ active clinical trials and 50+ CSUR rare disease accreditations.

Product overview

Vall d'Hebron Barcelona Hospital Campus is a leading healthcare campus comprising five institutions: Hospital Universitari Vall d'Hebron (general hospital care), VHIR (research institute), VHIO (oncology institute), CEMCAT (multiple sclerosis center), and UAB teaching unit. The campus offers comprehensive healthcare services including specialized treatments (transplants, CAR-T therapy, robotic surgery with Da Vinci systems), research programs, and teaching. Key digital/technological offerings include the El Meu Vall d'Hebron patient portal, Smart Campus mobile integration, the 3D Technologies Unit for custom medical devices, Clinical Simulation Center, Data Space for health data management, and various specialty services across oncology, cardiology, neurology, and more.

Differentiator

Problem solved

Functional benefit

Brands

• El Meu Vall d'Hebron: Private patient portal for managing appointments, accessing medical records, and communicating with healthcare providers
• Smart Campus
• Vall d'Hebron Podcast
• Innovation Week (Setmana de la Innovació)

Products and services

• El Meu Vall d'Hebron Private patient portal for managing appointments, accessing medical records, and communicating with healthcare providers; available to patients, families, and professionals.
• Transplant Program Comprehensive transplant program including kidney, lung, liver, and hematopoietic stem cell transplants. Achieved 100+ lung transplants in 2025 and performed the first HIV-to-HIV kidney transplant in Spain using robotic surgery.
• CAR-T Therapy Program Cellular therapy program treating patients with CAR-T cells, including age-appropriate CAR-T treatment for aggressive lymphoma in elderly patients.
• Robotic Surgery (Da Vinci) Service Robotic surgical procedures using Da Vinci surgical systems (S and Xi) across urology, pediatric surgery, and transplant procedures. First hospital in Spain with two Da Vinci robotic operating theatres.
• Espai de Dades (Data Space) Secure data environment connecting clinical and research data to accelerate innovation and continuous improvement in healthcare delivery.
• Centre de Simulació Clínica Avançada Advanced clinical simulation center providing training for healthcare professionals in realistic medical scenarios across multiple specialties.
• Unitat de Tecnologies 3D (3D Technologies Unit)

Quantifiable outcome

• 1,580 active clinical trials (2021 record, sustained high activity through 2025-2026)
• +8 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature12 records

Partnerships

One partnership is on record.

• Barcelona & Madrid Health HubcoreStrategic or Co-development Partner · 1 January 2023Renewed collaboration agreement (first established 2023) between Hospital Universitari Vall d'Hebron and VHIR with Barcelona & Madrid Health Hub, a non-profit association promoting digital health innovation. The partnership aims to accelerate digital transformation in healthcare by sharing knowledge, experience, and capabilities. Key objectives include creating standardized validation, testing, and implementation processes for startups' digital health products; defining common procedures for medical technology assessment; and facilitating faster adoption of innovative solutions into the health system. Barcelona & Madrid Health Hub connects startups, companies, investors, universities, and public/private organizations in the health sector.

Scale indicators9 records

Recent moves16 records

Expansion highlights6 records

Regional players

• Assistance Publique – Hôpitaux de Paris (AP-HP): Network of 38 public hospitals in the Paris region including several reference academic centers (e.g., Pitié-Salpêtrière, Necker). Comparable in scale, CSUR-equivalent reference designations, and integrated research structure; not a direct same-territory competitor.
• Karolinska University Hospital: Swedish public academic hospital with integrated research (Karolinska Institutet). Comparable model of university hospital plus research institute; peer in advanced therapies, transplant programs, and rare disease ERN participation.
• Charité – Universitätsmedizin Berlin: Germany's largest public university hospital with joint medical faculty of Humboldt and Freie Universität. Comparable in scale (10,000+ staff range), research output, advanced therapy programs, and European reference center status.

Direct peers

• Hospital Universitario Cruces: Basque Country public university hospital with strong transplant and pediatric programs. Peer in CSUR accreditations and competes with Vall d'Hebron for northern-Spain tertiary referrals and clinical trial site selection.
• Hospital Universitario La Paz: Madrid-based public university hospital, one of Spain's largest reference centers with broad specialty coverage and a comparable teaching hospital model. Competes with Vall d'Hebron for national CSUR designations, residency talent, and complex pediatric and transplant referrals.
• Hospital Universitario Virgen del Rocío: Major Seville-based public university hospital and reference center for southern Spain. Comparable in transplant volume, pediatric care, and CSUR accreditations; competes for national reference status and EU research grants.
• Hospital Universitario 12 de Octubre: Madrid public university hospital comparable in scale and scope, with strong transplant, oncology, and research programs. Direct peer in CSUR designations and IQVIA Prime Site-style clinical trial activity.
• Hospital de la Santa Creu i Sant Pau: Barcelona-based public university hospital with an embedded research institute (IIB Sant Pau). Operates in the same metropolitan market and competes for tertiary referrals, residency positions, and biomedical research funding in Catalonia.
• Hospital Clínic de Barcelona: Public university hospital in Barcelona with comparable scale, transplant volume, and integrated research structure (IDIBAPS). Direct competitor for tertiary referrals in Catalonia and Spain, and peer in clinical trial activity and CSUR designations.
• Hospital General Universitario Gregorio Marañón: Madrid public university hospital with overlapping transplant, oncology, and pediatric programs. Peer in CSUR designations and a direct competitor for Spanish reference status across multiple specialties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC5yvGvXa-CqW4qJ2Y5eKL4A
• Facebookfacebook.com/vallhebroncampus
• Xx.com/hvhebron
• LinkedInlinkedin.com/company/vallhebron

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vall d'Hebron Hospital General